Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BCG-Russia + oral polio vaccine
- Development stage
- Unknown
- Lead developer
- Serum Institute of India
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal, Oral
01
Overview
BCG-Russia + oral polio vaccine is a combination vaccine intervention consisting of the Russian strain of the live attenuated Bacillus Calmette-Guérin (BCG) vaccine and the live attenuated oral polio vaccine (OPV). This combination was primarily investigated in randomized controlled trials in India to determine if its administration at birth could reduce neonatal mortality in low birth weight infants (weighing <2000 g) through non-specific immune-modulating effects, often referred to as trained immunity. While BCG and OPV are standard vaccines for tuberculosis and poliomyelitis respectively, this specific research focused on their potential to reduce deaths from unrelated infections such as pneumonia and sepsis. Clinical trial results demonstrated that the combination did not significantly impact neonatal mortality rates in the studied population compared to control groups.
- Other names
- BCG-Russia + OPVBCG-Russia and oral polio vaccine
Beyond the preview
Go deeper on BCG-Russia + oral polio vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BCG-Russia + oral polio vaccine.